Abstract
OBJECTIVES: Uncoupling protein 2 (UCP2) is a recently described homologue of the uncoupling protein of brown adipocytes (UCP1), which is expressed at high levels in human white adipose tissue. Studies were undertaken (1) to establish whether the expression of UCP2 mRNA varies in a depot-related manner in isolated human adipocytes, (2) to determine whether thiazolidinedione exposure influences the expression of UCP2 mRNA in cultured human pre-adipocytes, and (3) to determine whether human UCP2 is targeted to mitochondria when transfected into mammalian cells.
SUBJECTS: Abdominal subcutaneous and omental adipose tissue biopsies were obtained from adult patients undergoing elective intra-abdominal surgical procedures.
MEASUREMENTS: A competitive reverse transcriptase-polymerase chain reaction (RT-PCR) was used to quantify UCP2 mRNA expression in human omental and subcutaneous adipocytes, and in cultured human preadipocytes differentiated in vitro using the thiazolidinedione, BRL49653. Chinese hamster ovary cells were transfected with a vector expressing human UCP2, and its cellular localization was determined by confocal immunofluorescence microscopy.
RESULTS: Adipocytes isolated from human omentum consistently expressed more UCP2 mRNA than did subcutaneous adipocytes from the same subjects (mean fold difference 2.92±0.44 P<0.001, n=11) with no effect of gender or body mass index being seen. BRL49653 treatment of subcutaneously, but not omentally, derived preadipocytes stimulated expression of UCP2 mRNA (5.1±1.1 fold). Transfected human UCP2 was detected exclusively in mitochondria of CHO cells.
CONCLUSIONS: Increased expression of UCP2 in human omental adipose tissue relative to subcutaneous adipose tissue is related to the expression levels in adipocytes per se, a finding which may relate to the particular functional attributes of this sub-population of adipocytes. Furthermore, BRL 49653 has site-specific effects of on the expression of UCP2 in human preadipocytes, a finding which may be relevant to the therapeutic effects of such compounds. Finally we present evidence for the mitochondrial localisation of human UCP2.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Fleury C, Neverova M, Collins S, Raimbault S, Champigny O, Levimeyrueis C, Bouillaud F, Seldin MF, Surwit RS, Ricquier D, Warden CH . Uncoupling protein-2: a novel gene linked to obesity and hyperinsulinaemia Nature Genet 1997 15: 269–272.
Gimeno RE, Dembski M, Weng X, Deng N, Shyjan A, Gimeno CJ, Iris F, Ellis SJ, Woolf EA, Tartaglia LA . Cloning and characterisation of an uncoupling protein homolog: a potential molecular mediator of human thermogenesis Diabetes 1997 46: 900–906.
Boss O, Samec S, Paolini-Giacobino A, Rosier C, Dulloo A, Seydoux J, Muzzin P, Giacobino JP . Uncoupling protein-3: a new member of the mitochondrial carrier family with tissue specific expression FEBS Lett 1997 408: 39–42.
Bouchard C, Pérusse L, Chagnon YC, Warden C, Riquier D . Linkage between markers in the vicinity of the uncoupling protein-2 gene and resting metabolic rate in humans Hum Mol Genet 1997 6: 1887–1889.
Walder K, Norman RA, Hanson RL, Schrauwen P, Neverova M, Jenkinson CP, Easlick J et al.Association between uncoupling protein polymorphisms (UCP2-UCP3) and energy metabolism/obesity in Pima Indians Hum Mol Genet 1998; 7: 1431–1435.
Gong DW, He Y, Karas M, Reitman M . Uncoupling protein-3 is a mediator of thermogenesis regulated by thyroid hormone, beta 3-adrenergic agonists, and leptin J Biol Chem 1997 272: 24129–24132.
Millet L, Vidal H, Andreeli F, Larrouy D, Riou JP, Ricquier D, Laville M, Langin D . Increased uncoupling protein-2 and -3 mRNA expression during fasting in obese and lean humans. J Clin Invest 1997 100: 2665–2670.
Matsuda Hosoda J, Itoh K, Son H, Doi C, Tanaka K, Fukunaga T, Inoue Y, Nishimura G, Yoshimasa H, Yamori Y, Nakao YK . Cloning of rat uncoupling protein-3 and uncoupling protein-2 cDNAs: their gene expression in rats fed high-fat diet FEBS Lett. 1997 418: 200–204.
Surwit RS, Wang S, Petro AE, Sanchis D, Raimbault S, Ricquier D, Collins S . Diet-induced changes in uncoupling proteins in obesity-prone and obesity-resistant strain of mice Proc Nat Acad Sci USA 1998 95: 4061–4065.
Rebuffé-Scrive M, Andersson B, Olbe L, Bjorntorp P . Metabolism of adipose tissue in intra-abdominal depots of non-obese men and women Metabolism 1989 38: 453–458.
Martin ML, Jensen MD . Effects of body distribution on regional lipolysis in obesity J Clin Invest 1991 88: 609–613.
Arner P . Differences in lipolysis between human subcutaneous and omental adipose tissues Ann Med 1995 27: 435–438.
Oberkofler H, Liu YM, Esterbauer H, Hell E, Krempler F, Patsch W . Uncoupling protein-2 gene: reduced mRNA expression in intraperitoneal adipose tissue of obese humans Diabetologia 1998 41: 940–946.
Day C . Thiazolidinediones: a new class of antidiabetic drugs Diabetic Med 1999 16: 179–192.
Lehmann JM, Moore LB, Smith-Oliver TA, Wilkison WO, Willson TM, Kliewer SA . An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor-γ (PPARγ) J Biol Chem 1995 270: 12953–12956.
Adams M, Montague CT, Prins JB, Holder JC, Smith SA, Sanders L, Digby JE, Sewter CP, Lazar MA, Chaterjee KK, O'Rahilly S . Activators of peroxisome proliferator-activated receptor-g have depot-specific effects on human preadipocyte differentiation J Clin Invest 1997 100: 3149–3153.
Spiegelman BM . PPAR-γ adipogenic regulator and thiazolidinedione receptor Diabetes 1998 47: 507–514.
Rothwell NJ, Stock MJ, Tedstone AE . Effects of ciglitazone on energy balance, thermogenesis and brown fat activity in the rat Mol Cell Endocrinol 1987 57: 253–257.
Digby JE, Montague CT, Sewter CP, Sanders L, Wilkison WO, O'Rahilly S, Prins J . Thiazolidinedione exposure increases the expression of uncoupling protein 1 in cultured human preadipocytes Diabetes 1998 47: 138–141.
Camirand A, Marie V, Rabelo R, Silva JE . Thiazolidinediones stimulate uncoupling protein-2 expression in cell lines representing white and brown adipose tissue and skeletal muscle Endocrinology 1998 139: 428–431.
Matsuda J, Hosada K, Itoh H, Son C, Doi K, Hanaoka I, Inoue G, Nishimura H, Yoshimasa Y, Yamori Y, Odaka H and Nakao K . Increased adipose expression of the uncoupling protein-3 gene by thiazolidinediones in Wistar Fatty rats and in cultured adipocytes Diabetes 1998 47: 1809–1814.
Rodbell M . Metabolism of isolated fat cells J Biol Chem 1964 239: 375–380.
Hauner H, Entenmann G, Wabitsch M, Gaillard D, Ailhaud G, Negrel R, Pfeiffer EF . Promoting effect of glucocorticoids on the differentiation of human adipocyte precursor cells in a chemically defined medium J Clin Invest 1989 84: 1663–1670.
Montague CT, Prins JB, Sanders L, Digby JE, O'Rahilly S . Depot- and sex-specific differences in human leptin mRNA expression Diabetes 1997 46: 342–347.
Montague CT, Prins JB, Sanders L, Zhang J, Sewter CP, Digby J, Byrne CD, O'Rahilly S . Depot-related gene expression in human subcutaneous and omental adipocytes Diabetes 1998 47: 1384–1391.
Sewter CP, Digby JE, Blows F, Prins J, O'Rahilly S . Regulation of tumour necrosis factor-alpha release from human adipose tissue in vitro. J Endocrinol 1999 163: 33–38.
Dib K, Whitehead JP, Humphreys PJ, Soos MA, Baynes KRC, Kumar S, Harvey T, O'Rahilly S . Impaired activation of phosphinositide 3-kinase by insulin in fibroblasts from patients with severe insulin resistance and pseudo-acromegaly: a disorder characterised by selective post-receptor insulin resistance J Clin Invest 1998 101: 1111–1120.
Qian H, Hausman GJ, Compton MM, Azain MJ, Hartzell DL, Baile CA . Leptin regulation of peroxisome proliferator-activated receptor-γ, tumor necrosis factor, and uncoupling protein-2 expression in adipose tissue Biochem Biophys Res Commun 1998 246: 660–667.
Kissebah AH, Vydelingum N, Murray M, Evans DJ, Hartz AJ, Kalkhoff RK, Adams PW . Relation of body fat distribution to metabolic complications of obesity J Clin Endocinol Metab 1982 54: 254–260.
Krotkiewski M, Bjorntorp P, Sjostrom L, Smith U . Impact of obesity on metabolism in men and women: importance of regional adipose tissue distribution J Clin Invest 1983 72: 1150–1162.
Ross R, Fortier L, Hudson R . Separate associations between visceral and subcutaneous adipose tissue distribution, insulin and glucose levels in obese women Diabetes Care 1996 19: 1404–1411.
Carey DG, Jenkins AB, Campbell LV, Freund J, Chisholm DJ . Abdominal fat and insulin resistance in normal and overweight women-direct measurements reveal a strong relationship in subjects at both low and high risk of NIDDM Diabetes 1996 45: 633–638.
Fried SK, Russell CD, Grauso NL, Brolin RE . Lipoprotein lipase regulation by insulin and glucocorticoid in subcutaneous and omental adipose tissues of obese women and men J Clin Invest 1993 92: 2191–2198.
Samec S, Seydoux J, Dulloo AG . Interorgan signalling between adipose tissue and skeletal muscle uncoupling protein homologs. Is there a role for circulating free fatty acids? Diabetes 1998 47: 1693–1698.
Wahrenberg H, Lonnqvist F, Armer P . Mechanisms underlying regional differences in lipolysis in human adipose tissue J Clin Invest 1989 84: 458–467.
Richelsen B, Pedersen SB, Moller-Pedersen T, Bak JF . Regional differences in triglyceride breakdown in human adipose tissue: effects of catecholamines, insulin and prostaglandin e2 Metabolism 1991 40: 990–996.
Bolinder J, Kager L, Östmann J, Arner P . Differences at the receptor and post receptor levels between human omental and subcutaneous adipose tissue in the action of insulin on lipolysis Diabetes 1983 32: 117–123.
Acknowledgements
This work was supported by a grant from Glaxo Wellcome (JD, SOR). SOR, JBP, JPW and VEFC are supported by the Wellcome Trust and CS by the British Diabetic Association. We would like to thank Professor Ken Siddle for his help in the development of the anti-UCP2 antibody. The assistance of members of the Departments of Surgery and Obstetrics and Gynaecology of Addenbrooke's Hospital and the University of Cambridge, in particular Peter Friend, Neville Jamieson, John Williamson and Michael Bright is also greatly appreciated.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Digby, J., Crowley, V., Sewter, C. et al. Depot-related and thiazolidinedione-responsive expression of uncoupling protein 2 (UCP2) in human adipocytes. Int J Obes 24, 585–592 (2000). https://doi.org/10.1038/sj.ijo.0801201
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.ijo.0801201
Keywords
This article is cited by
-
Profile of Adipose-Derived Stem Cells in Obese and Lean Environments
Aesthetic Plastic Surgery (2019)
-
PPARγ activity in subcutaneous abdominal fat tissue and fat mass gain during short-term overfeeding
International Journal of Obesity (2006)